Neuroquímida y Neurodegeneración
Columbia University
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Columbia University (4)
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
2019
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
2013
-
Conformational plasticity of the essential membrane-associated mannosyltransferase PimA from mycobacteria
Journal of Biological Chemistry, Vol. 288, Núm. 41, pp. 29797-29808